Research Article
[Retracted] Bevacizumab Combined with Intensity-Modulated Radiation Therapy on Cognitive and Coagulation Function in Postoperative Glioma Patients
Table 1
General baseline information (‾x ± s/n(%)).
| | | Control group (n = 77) | Observation group (n = 79) | χ2/t | P |
| | Gender [n(%)] | | | 0.0219 | 0.8821 | | Male | 41(53.2) | 43(54.4) | | | | Female | 36(46.8) | 36(45.6) | | | | Average age (years,‾x ± s) | 57.32 ± 6.43 | 58.02 ± 6.95 | 0.6526 | 0.5150 | | Pathological pattern | | | 0.3095 | 0.8566 | | Neuroastrocytoma | 47(61.0) | 45(57.0) | | | | Oligodendroglioma | 16(20.8) | 19(24.1) | | | | Mixed glioma | 14(18.2) | 15(18.9) | | | | Lesion | | | 1.2584 | 0.8685 | | Frontal lobe | 32(41.6) | 30(38.0) | | | | Occipital lobe | 11(14.3) | 14(17.7) | | | | Temporal lobe | 19(24.7) | 20(25.3) | | | | Parietal lobe | 13(16.9) | 11(13.9) | | | | Others | 2(2.5) | 4(5.1) | | | | Postoperative pathological grading | | | 0.0855 | 0.7700 | | III | 46(59.7) | 49(62.0) | | | | IV | 31(40.3) | 30(38.0) | | | | Tumour diameter (cm,‾x ± s) | 4.12 ± 0.87 | 4.02 ± 1.04 | 0.6506 | 0.5163 | | Degree of surgical resection | | | 0.2059 | 0.6500 | | Complete excision | 52(67.5) | 56(70.9) | | | | Partial excision | 25(32.5) | 23(29.1) | | | | Combined underlying disease | | | 0.2627 | 0.6083 | | Diabetes | 15(19.5) | 14(17.7) | | | | Hypertension | 21(27.3) | 25(31.6) | | |
|
|
Chi-square test, fisher's exact test, or independent sample t-test between groups.
|
